Compare PEPG & CAL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | PEPG | CAL |
|---|---|---|
| Founded | 2018 | 1878 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Shoe Manufacturing |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 440.0M | 400.3M |
| IPO Year | 2022 | 1994 |
| Metric | PEPG | CAL |
|---|---|---|
| Price | $6.72 | $11.43 |
| Analyst Decision | Strong Buy | Hold |
| Analyst Count | 6 | 1 |
| Target Price | $11.67 | ★ $14.00 |
| AVG Volume (30 Days) | ★ 597.7K | 475.0K |
| Earning Date | 01-01-0001 | 03-09-2026 |
| Dividend Yield | N/A | ★ 2.50% |
| EPS Growth | ★ 13.64 | N/A |
| EPS | N/A | ★ 0.47 |
| Revenue | N/A | ★ $85,513,000.00 |
| Revenue This Year | N/A | $3.57 |
| Revenue Next Year | N/A | $4.11 |
| P/E Ratio | ★ N/A | $23.77 |
| Revenue Growth | N/A | ★ 0.46 |
| 52 Week Low | $0.89 | $9.54 |
| 52 Week High | $7.80 | $18.08 |
| Indicator | PEPG | CAL |
|---|---|---|
| Relative Strength Index (RSI) | 59.75 | 40.52 |
| Support Level | $4.36 | $10.33 |
| Resistance Level | $6.81 | $11.84 |
| Average True Range (ATR) | 0.60 | 0.63 |
| MACD | 0.04 | -0.09 |
| Stochastic Oscillator | 70.57 | 31.48 |
PepGen Inc is a clinical-stage biotechnology company advancing the next generation of oligonucleotide therapeutics to transform the treatment of severe neuromuscular and neurologic diseases. The company has developed its Enhanced Delivery Oligonucleotide platform to improve the uptake and activity of conjugated oligonucleotide therapeutics. Its EDO peptides are engineered to optimize tissue penetration, cellular uptake, and nuclear delivery, and in preclinical studies, it is observed their ability to transport oligonucleotides into a broad range of target tissues, including smooth, skeletal, and cardiac muscle and the central nervous system. Its pipeline products are; PGN-EDO51, PGN-EDODM1, and others including PGN-EDO53 and PGN-EDO45.
Caleres Inc is a footwear company that operates retail shoe stores and e-commerce websites, and designs, develops, sources, manufactures, and distributes footwear for people of all ages. The Company's business operations are organized into two reportable segments - famous Footwear and Brand Portfolio. The famous Footwear segment is comprised of its famous Footwear retail stores, famousfootwear.com, and famousfootwear.ca. The famous Footwear segment operated around 846 stores at the end of 2024. The Brand Portfolio segment offers retailers and consumers a cultivated portfolio of known brands. Geographically, the company generates the majority of its revenue from Domestic operations.